Compare SCL & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SCL | ETON |
|---|---|---|
| Founded | 1932 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1994 | 2018 |
| Metric | SCL | ETON |
|---|---|---|
| Price | $64.72 | $61.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $75.00 | $39.33 |
| AVG Volume (30 Days) | 135.7K | ★ 590.3K |
| Earning Date | 04-28-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | ★ $1,803,737,000.00 | $79,950,000.00 |
| Revenue This Year | $6.60 | $40.90 |
| Revenue Next Year | $5.27 | $47.23 |
| P/E Ratio | ★ N/A | $143.56 |
| Revenue Growth | N/A | ★ 104.94 |
| 52 Week Low | $41.82 | $14.27 |
| 52 Week High | $68.00 | $59.79 |
| Indicator | SCL | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 64.58 | 76.67 |
| Support Level | $48.96 | $15.77 |
| Resistance Level | $67.38 | N/A |
| Average True Range (ATR) | 1.93 | 3.15 |
| MACD | -0.10 | 0.91 |
| Stochastic Oscillator | 62.93 | 88.01 |
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.